Delivery Order SPE2DB25D3008-SPE2DB25FRBUR

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DX15D1053|SPE2DX25F6CTA) valued at $36,158.34 for the supply of the prescription drug Sprycel. The contract, which has a completion date of November 4, 2024, was awarded on November 1, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $55,285.69 delivery order contract is for the supply of 60-count tablets of Sprycel 50mg, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen, through its Corporate Office division, will provide the requested pharmaceutical product to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $18,774.53, is for the delivery of the drug Sprycel 100 mg tablets. The award has a completion date of February 28, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,891.40 Firm Fixed Price delivery order is for the supply of SPRYCEL 50 MG TABLET 60S, a pharmaceutical product. The contract has a period of performance through February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $19,222.98, is for the delivery of Sprycel 100 mg tablets over a period ending on April 21, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,140.74, is a delivery order for the pharmaceutical product SPRYCEL 140 MG TABLET 30S. The contract has a firm fixed price pricing type and a completion date of April 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award with the Defense Logistics Agency (DLA) is for the delivery of Sprycel 100 MG Tablets in a 30-count package. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical supplier to the U.S. federal government, on June 28, 2024. The firm-fixed-price delivery order has a ceiling value of $26,750.22 and an ultimate completion date of July 1, 2024. This contract is not designated as a set-aside. Amerisourcebergen, through its Corporate Office Division,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,142,252 units of the prescription medication Sprycel (100 mg tablet, 30-count) at a ceiling value of $11,701.09. The contract is a firm-fixed price, non-set-aside award with a period of performance through May 6, 2025. AmerisourceBergen holds a substantial Indefinite...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $6,334.69 for the pharmaceutical product SPRYCEL 50 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 3, 2025. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Sprycel 100 mg tablets. The $16,006.11 firm-fixed-price delivery order contract has a completion date of June 21, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA to provide a comprehensive...
  • SPE2DB25D3008
    Indefinite Delivery Contract
  • SPE2DB25D3008-SPE2DB25FRBUR
    Delivery Order

This federal contract award, valued at $30,962.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Sprycel 50 mg tablets. This contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, Pennsylvania. The contract has an ultimate completion date of April 16, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/15/25, 3:51 PM